stoxline Quote Chart Rank Option Currency Glossary
Applied DNA Sciences, Inc. (APDN)
0.4406  0.009 (1.99%)    07-12 14:42
Open: 0.4268
High: 0.4478
Volume: 339,827
Pre. Close: 0.4319
Low: 0.41
Market Cap: 4(M)
Technical analysis
2024-07-12 2:19:47 PM
Short term     
Mid term     
Targets 6-month :  0.58 1-year :  0.7
Resists First :  0.49 Second :  0.6
Pivot price 0.44
Supports First :  0.33 Second :  0.27
MAs MA(5) :  0.44 MA(20) :  0.45
MA(100) :  5.15 MA(250) :  14.14
MACD MACD :  -0.3 Signal :  -0.4
%K %D K(14,3) :  49.8 D(3) :  50.4
RSI RSI(14): 28.3
52-week High :  37.2 Low :  0.33
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ APDN ] has closed below upper band by 49.2%. Bollinger Bands are 94.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.47 - 0.48 0.48 - 0.48
Low: 0.4 - 0.41 0.41 - 0.41
Close: 0.44 - 0.44 0.44 - 0.44
Company Description

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Headline News

Sun, 07 Jul 2024
Applied DNA Sciences (NASDAQ:APDN) Receives New Coverage from Analysts at - Defense World

Thu, 27 Jun 2024
Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Thu, 30 May 2024
Applied DNA Sciences’ $12M Securities Offering and Agreement - TipRanks

Tue, 28 May 2024
Applied DNA announces $12 million public offering -

Tue, 28 May 2024
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga

Tue, 28 May 2024
Applied DNA Announces Pricing of $12 Million Public Offering - AccessWire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Diagnostics & Research
Shares Out 9 (M)
Shares Float 1 (M)
Held by Insiders 3.4 (%)
Held by Institutions 8.4 (%)
Shares Short 784 (K)
Shares Short P.Month 159 (K)
Stock Financials
EPS -17.63
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.06
Profit Margin -222.4 %
Operating Margin -389.2 %
Return on Assets (ttm) -63.7 %
Return on Equity (ttm) -252.4 %
Qtrly Rev. Growth -79 %
Gross Profit (p.s.) 0
Sales Per Share 0.61
EBITDA (p.s.) -1.48
Qtrly Earnings Growth 0 %
Operating Cash Flow -11 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -0.03
PEG Ratio 0
Price to Book value -7.41
Price to Sales 0.72
Price to Cash Flow -0.37
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android